SCHEMBL22831750

SCHEMBL22831750

O=c1c2ccccc2n(CCCO)c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.56
SLC6A2 P23975 1/20 0.56
HRH1 P35367 1/20 0.56
ALDH1A1 P00352 2/20 0.56
GLA P06280 1/20 0.56
FABP4 P15090 2/20 0.54
FABP5 Q01469 2/20 0.54
P2RX4 Q99571 1/20 0.53
HPGD P15428 1/20 0.51
TP53 P04637 2/20 0.51
MAPT P10636 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ABCB1 P08183 4/20 0.50
HDAC1 Q13547 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31184256 1.00 SLC6A4 (0.56) SLC6A4SLC6A2HRH1ALDH1A1GLA
SCHEMBL31124810 0.89 ALDH1A1 (0.60) SLC6A4SLC6A2HRH1ALDH1A1GLA
SCHEMBL31739357 0.88 FABP4 (0.61) FABP4FABP5HDAC1HDAC6MEN1
SCHEMBL8204008 0.88 FABP4 (0.61) FABP4FABP5HDAC1HDAC6MEN1
SCHEMBL2873004 0.82 FABP4 (0.62) FABP4FABP5HDAC1HDAC6MEN1
SCHEMBL15835242 0.81 SLC6A4 (0.56) SLC6A4SLC6A2HRH1ALDH1A1GLA
SCHEMBL10730998 0.81 PGR (0.70) SLC6A4SLC6A2HRH1ALDH1A1GLA
SCHEMBL24398894 0.81 FABP4 (0.61) FABP4FABP5HDAC1HDAC6MEN1
SCHEMBL3066305 0.81 FABP4 (0.61) FABP4FABP5HDAC1HDAC6MEN1
SCHEMBL30622271 0.81 FABP4 (0.61) FABP4FABP5HDAC1HDAC6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509428-B2 Polymerizable fused tricyclic compounds as absorbers of UV and visible light JOHNSON & JOHNSON VISION CARE, INC. (US) 2025-12-30 US disclosed
US-20230117655-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. 2023-04-20 US disclosed
EP-3990431-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT Johnson & Johnson Vision Care, Inc. (US) 2022-05-04 EP disclosed
CN-112449635-A Polymerizable fused tricyclic compounds as absorbers of UV and visible light 强生视力健公司 2021-03-05 CN disclosed
US-20200407324-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. 2020-12-31 US disclosed
WO-2020260684-A1 AN OPTICAL SENSOR Københavns Universitet (DK) 2020-12-30 WO disclosed
WO-2020261021-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. (US) 2020-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200407324-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT ERCC4, ERCC1, F12 SLC6A4 2966/4885SLC6A2 3711/4885HRH1 289/4885
US-12509428-B2 Polymerizable fused tricyclic compounds as absorbers of UV and visible light ERCC1, OGG1, ERCC4 SLC6A4 566/4885SLC6A2 1480/4885HRH1 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.